FREESTYLE DIGITAL MEDIA RELEASES COMEDY MOVIE“LEFT AT WALL”
Freestyle Digital media proudly announces the release of the workplace comedy movie LEFT AT WALL, now available to rent/own on all North American digital HD internet, cable, and satellite platforms, ...
Future Market Insights6d
Global Pharmaceutical Sterility Testing Market Set for Explosive Growth, Projected to Reach USD 3,815.6 Million by 2033 develop at a CAGR of 11.8%
The global pharmaceutical sterility testing market is on the brink of an extraordinary expansion, with forecasts predicting a ...
Future Market Insights8d
Global Allogeneic T-cell Therapies Market Poised for Significant Growth, Projected to Reach USD 3.08 Billion by 2033 register a CAGR of 9.8%
According to a recent report from Future Market Insights, the global allogeneic T-cell therapies market was valued at USD 1.1 ...
MM&M14d
Rx Rundown: Verdiva, Johnson & Johnson, Transcarent and more
OMNY Health is partnering with Scipher Medicine. Vertex Pharmaceuticals signed a three-year deal with Orna Therapeutics to use the RNA biotech’s delivery particles to develop its next iteration of ...
Business Insider14d
Mersana Therapeutics: Promising Clinical Data and Strong Financial Position Justify Buy Rating
Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target at $8.00. Discover outperforming stocks and invest ...
The Business Journals15d
Why biotech startup Tenvie sees promise in drugs from founders' old company
Tenvie Therapeutics Inc. is getting a set of small-molecule drugs — specifically, ones aimed at tamping down inflammation, rescuing metabolic dysfunction and restoring lysosomal function ...
Mena FN16d
Tenvie Therapeutics Launches With $200 Million To Deliver Breakthrough Small Molecule Therapies
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics launched today with a commitment to transform the treatment of neurological diseases. The company combines a deep and diverse portfolio of ...
FierceBiotech16d
Arch-backed Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.
STAT16d
Denali Therapeutics spinout raises $200M as neuro company resets
A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...
manilatimes16d
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics launched today with a commitment to transform the treatment of neurological diseases. The company combines a deep and diverse portfolio of small ...
PharmiWeb23d
Peptide Synthesis Industry Set to Double, Reaching USD 1.1 Billion by 2033 with an 8% CAGR
The market’s expansion is fueled by increased research into peptide-based therapeutics, advancements in synthesis ... Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater ...